The genetic predisposition to interstitial lung disease: Functional relevance

Chest

Volumn 121, Issue 3, 2002, Pages 14S-20S

  Du Bois, R M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Candidate genes; Genetics; Idiopathic pulmonary fibrosis; Sarcoidosis; Single nucleotide polymorphisms; Systemic sclerosis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; GENE PRODUCT; HLA ANTIGEN CLASS 1; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1ALPHA; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MONOCYTE CHEMOTACTIC PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

CONFERENCE PAPER; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FIBROSING ALVEOLITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS; SYSTEMIC SCLEROSIS;

EID: 0036128213     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0012-3692(15)35435-0     Document Type: Conference Paper

References (53)

1. Case-control association studies for the genetics of complex respiratory diseases
2. Class II HLA associations with autoantibodies in scleroderma: A highly significant role for HLA-DP
3. HLA and autoimmunity in scleroderma (systemic sclerosis)
4. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors
5. Epidemiology, demographics, and genetics of sarcoidosis
6. Epidemiology of familial sarcoidosis in the UK
7. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
8. Increased HLA-B7 antigen frequency in South Carolina blacks in association with sarcoidosis
9. HLA and sarcoidosis in the Japanese
10. " The sarcoidosis map": A joint survey of clinical and immunogenetic findings in two European countries
11. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis
12. Role of HLA-DR antigens in Japanese patients with sarcoidosis
13. Analysis of restriction length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis
14. Genetic aspects of sarcoidosis: Class II histocompatibility antigens and a family study
15. TNF-α and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis
16. HLA-DRB1 position 11 residues are a common protective marker for sarcoidosis
17. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis
18. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
19. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles
20. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis
21. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis
22. Familial sarcoidosis is linked to the major histocompatibility complex region
23. HLA-DPB1 and TAP1 polymorphisms in sarcoidosis
24. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis
25. Tumour necrosis factor α promoter gene polymorphism in sarcoidosis
26. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese
27. Single base polymorphism in the human tumour necrosis factor α (TNFα) gene detectable by NcoI restriction of PCR product
28. No independent association between a tumor necrosis factor-α promoter region polymorphism and insulin-dependent diabetes mellitus
29. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus
30. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles: Relevance for inflammatory bowel disease
31. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
32. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis
33. Polymorphisms at position -308 in the promoter region of the TNF-α and in the first intron of the TNF-β genes and spontaneous and lipopolysaccharide-induced TNF-α release in sarcoidosis
34. The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans
35. Macrophage inflammatory protein-1 α expression in interstitial lung disease
36. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
37. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis
38. Vitamin D receptor gene polymorphism in patients with sarcoidosis
39. Genetics of host resistance and susceptibility to intramacrophage pathogens: A study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil
40. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis
41. ACE gene I/D polymorphism and pulmonary disease severity
42. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis
43. Clinical value of ACE genotyping in diagnosis of sarcoidosis
44. Interpopulation effect of ACE I/D polymorphism on serum concentration of ACE in diagnosis of sarcoidosis
45. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis
46. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis
47. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients
48. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis
49. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients
50. Angiotensin-converting enzyme (ACE) gene polymorphism in patients with sarcoidosis
51. A mutation in the surfactant protein C gene associated with familial interstitial lung disease
52. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms
53. Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis